NCT03708068

Brief Summary

Enteral nutrition in preterm infants is usually started and advanced slowly until reaching full enteral feeds. Most preterm infants born before 34 weeks gestation require parenteral fluids to maintain normal blood sugar level and prevent excessive weight loss and dehydration. Availability of donor human milk (DHM) along with low incidence of necrotizing enterocolitis (NEC) in preterm infants born at 30-33 weeks have encouraged neonatologists to start feeding early and advance it faster in order to shorten time on parenteral nutrition (PN) and minimize the need for intravenous access. The objectives of this trial is to study whether exclusive enteral nutrition from day of birth (i.e. no PN) results in shorter time to achieve full enteral feed when compared with traditional feeding regimen that involves a combination of PN and progressive enteral feeding.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 16, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

April 16, 2019

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

4.5 years

First QC Date

October 1, 2018

Last Update Submit

April 19, 2024

Conditions

Keywords

ExclusiveEnteral NutritionPreterm Infant

Outcome Measures

Primary Outcomes (1)

  • Duration to achieve of full enteral feeds in days

    Day of life to achieve full enteral feeding defined as 140 ml/kg/day which is sustained for at least 3 days

    Till 30 days of life

Secondary Outcomes (5)

  • Length of hospital stay

    At discharge from neonatal intensive care unit (NICU), up to 90 days of life

  • Feeding intolerance

    Till 30 days of life

  • Incidence of late onset sepsis

    At discharge from NICU, up to 90 days of life

  • Incidence of NEC

    At discharge from NICU, up to 90 days of life

  • Incidence of hypoglycemia

    Till 30 days of life

Study Arms (2)

Early Exclusive Enteral Nutrition

EXPERIMENTAL

Feeds will start at least at 80% of reference daily fluid intake from day one of life. Feeds will be advanced by 20-30 ml/kg per day on second day onwards until infant reaches full enteral feed.

Other: Early exclusive enteral nutrition

Conventional Enteral Nutrition

NO INTERVENTION

Infants will be fed as per current Neonatal Intensive Care Unit feeding tables: 1. Infants with birth weight 1000-1500 g will be fed on 15-20 ml/kg human milk in day one. Feeds will be advanced by 15-20 ml/kg per day on second day onwards until infant reaches full enteral feeds. 2. Infants with birth weight \>1500 g will be started on 20-30 ml/kg per day on day one. Feeds will be advanced by 20-30 ml/kg per day on second day onwards until infant reaches full enteral feeds.

Interventions

Infants will be fed at least 80% of reference daily fluid intake from day one. Feeds will be advanced by 20-30 ml/kg per day on second day onwards to meet reference daily fluid intake until infant reaches full enteral feed.

Also known as: Early Total Enteral Feed
Early Exclusive Enteral Nutrition

Eligibility Criteria

AgeUp to 48 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants born at 30 0/7 - 33 6/7 weeks gestation
  • Birth weight greater than 1000 g
  • Consent to use donor human milk
  • Postnatal age is less than 48 hours from birth
  • Infant is ready to start on feeding (as per clinical team) or feeding volume, when already started, is ≤12 ml/kg per day (total) and/or the infant received ≤2 feeds based on current feeding policy or physician descrition (total volume of the received feeds is ≤20 ml/kg per day).

You may not qualify if:

  • Cord PH \< 7.00 or Cord base access (BE) \< -16
  • Apgar score \< 7 at 5 minute
  • Lactate level ≥3 (if done for clinical indication)
  • Need for positive pressure ventilation (PPV) for \>1 minute.
  • Hemodynamic instability (hypotension or poor perfusion at any time in this 48 hours)
  • Small for gestational age \<3 percentile on Fenton chart and/or fetal absent or reversed umbilical arterial end-diastolic blood flow.
  • Major congenital malformation
  • Symptomatic or severe hypoglycemia (blood glucose \<1.8 mmol/L)
  • Infants with moderate to severe respiratory distress.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Peter Lougheed Hospital

Calgary, Alberta, T1Y6J4, Canada

Location

Foothills Medical Centre

Calgary, Alberta, T2N2T9, Canada

Location

South Health Campus

Calgary, Alberta, T3M1P9, Canada

Location

Related Publications (1)

  • Alshaikh BN, Hassan O, Alburaki W, Dharel D, Elsharkawy A, Singal N, Yusuf K, Awad EA. Early exclusive enteral feeding in 30-33 weeks gestation infants: a randomized controlled trial. J Perinatol. 2025 May;45(5):628-634. doi: 10.1038/s41372-025-02217-0. Epub 2025 Feb 2.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Belal Alshaikh, MD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Neonatologist

Study Record Dates

First Submitted

October 1, 2018

First Posted

October 16, 2018

Study Start

April 16, 2019

Primary Completion

October 24, 2023

Study Completion

January 30, 2024

Last Updated

April 22, 2024

Record last verified: 2024-04

Locations